BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16411875)

  • 1. Succimer therapy for congenital lead poisoning from maternal petrol sniffing.
    Powell ST; Bolisetty S; Wheaton GR
    Med J Aust; 2006 Jan; 184(2):84-5. PubMed ID: 16411875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC).
    McKay CA
    J Med Toxicol; 2013 Dec; 9(4):339-43. PubMed ID: 24178899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure.
    Counter SA; Ortega F; Shannon MW; Buchanan LH
    Int J Occup Environ Health; 2003; 9(2):164-8. PubMed ID: 12848245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead poisoning and chelation in a mother-neonate pair.
    Horowitz BZ; Mirkin DB
    J Toxicol Clin Toxicol; 2001; 39(7):727-31. PubMed ID: 11778671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of succimer chelation therapy on postural balance and gait outcomes in children with early exposure to environmental lead.
    Bhattacharya A; Shukla R; Auyang ED; Dietrich KN; Bornschein R
    Neurotoxicology; 2007 May; 28(3):686-95. PubMed ID: 17499360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
    Pediatr Res; 2000 Nov; 48(5):593-9. PubMed ID: 11044477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers.
    Burns CB; Currie B
    Aust N Z J Med; 1995 Jun; 25(3):197-203. PubMed ID: 7487685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Petrol sniffing in a pregnant Aboriginal population: a review of maternal and neonatal outcomes.
    Dodd J
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):420-3. PubMed ID: 11787917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute lead poisoning during the perinatal period. A case of encephalopathy in a six week old child treated by peritoneal dialysis].
    Besson-Leaud M; Lavaud J; Buneaux F; Gendrel D; Frejaville JP; Nordmann Y
    Ann Pediatr (Paris); 1977 May; 24(5):373-82. PubMed ID: 16211980
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal anomalies resulting from maternal bullet-related plumbism.
    Porter S; Hanley E; Sing RF
    J Trauma; 2004 Jun; 56(6):1353-5. PubMed ID: 15211150
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
    Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
    J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Labor at Term for Severe Antenatal Lead Poisoning.
    Mohan S; Mahonski S; Koziatek C; Cohen ET; Smith S; Su MK
    J Med Toxicol; 2023 Oct; 19(4):401-404. PubMed ID: 37365427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two dosing regimens of succimer in children with chronic lead poisoning.
    Farrar HC; McLeane LR; Wallace M; White K; Watson J
    J Clin Pharmacol; 1999 Feb; 39(2):180-3. PubMed ID: 11563411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.